Publications
Journal Article (35)
2012
Journal Article
23 (6), pp. 900 - 907 (2012)
Recombinant live vaccine candidates against tuberculosis. Current Opinion in Biotechnology
Journal Article
92 (6), pp. 535 - 542 (2012)
Mycobacterium tuberculosis volatiles for diagnosis of tuberculosis by Cricetomys rats. Tuberculosis
Journal Article
92 (6), pp. 447 - 452 (2012)
Detection and treatment of subclinical tuberculosis. Tuberculosis
Journal Article
490 (7421), pp. 477 - 478 (2012)
Stemming the red tide: Lab luminaries jostle with consumptive cultural icons in a vivid history of tuberculosis; review of Spitting Blood: The History of Tuberculosis. Nature
Journal Article
30 (52), pp. 7608 - 7614 (2012)
The recombinant tuberculosis vaccine rBCG ΔureC::hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells. Vaccine
Journal Article
16 (9), pp. 1140 - 1148 (2012)
Enabling biomarkers for tuberculosis control. International Journal of Tuberculosis and Lung Disease
Journal Article
30 (37), pp. 5578 - 5584 (2012)
A recombinant Bacille Calmette-Guerin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB/c mice. Vaccine
Journal Article
7 (7), e40221 (2012)
Biomarkers of Inflammation, Immunosuppression and Stress with Active Disease Are Revealed by Metabolomic Profiling of Tuberculosis Patients. PLoS ONE
Journal Article
33 (7), pp. 373 - 379 (2012)
Tuberculosis vaccine development: strength lies in tenacity. Trends in Immunology
Journal Article
7 (6), e39827 (2012)
The Proteasome System in Infection: Impact of beta 5 and LMP7 on Composition, Maturation and Quantity of Active Proteasome Complexes. PLoS ONE
Journal Article
7 (6), e39827 (2012)
The Proteasome System in Infection: Impact of beta 5 and LMP7 on Composition, Maturation and Quantity of Active Proteasome Complexes. PLoS ONE
Journal Article
30 (27), pp. 4040 - 4045 (2012)
Heterologous prime-boost regimen adenovector 35-circumsporozoite protein vaccine/recombinant Bacillus Calmette-Guerin expressing the Plasmodium falciparum circumsporozoite induces enhanced long-term memory immunity in BALB/c mice. Vaccine
Journal Article
7 (6), e38501 (2012)
Potential of Host Markers Produced by Infection Phase-Dependent Antigen-Stimulated Cells for the Diagnosis of Tuberculosis in a Highly Endemic Area. PLoS ONE
Journal Article
379 (9829), pp. 1902 - 1913 (2012)
Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet
Journal Article
109 (20), pp. 7853 - 7858 (2012)
Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
109 (20), pp. 7853 - 7858 (2012)
Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
20 (5), pp. 220 - 226 (2012)
Can the battle against tuberculosis gain from epigenetic research? Trends in Microbiology
Journal Article
36 (3 Sp. Iss. SI), pp. 514 - 532 (2012)
Mycobacterium tuberculosis: success through dormancy. FEMS MICROBIOLOGY REVIEWS
Journal Article
8 (5), e1002607 (2012)
Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go? PLoS Pathogens
Journal Article
13 (5), pp. 421 - 422 (2012)
The Else Kröner-Fresenius Immunology Award. NATURE IMMUNOLOGY